TET2 c.1916dup ;(p.N639Kfs*42)

Variant ID: 4-106157013-G-GA

NM_001127208.2(TET2):c.1916dup;(p.N639Kfs*42)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study.

The Lancet. Haematology
,
Publication Date: 2022-11-24

Variant appearance in text: TET2: 1916dup
PubMed Link: 36436542
Variant Present in the following documents:
  • mmc2.xlsx, sheet 1
View BVdb publication page



The Importance of Targeted Next-Generation Sequencing Usage in Cytogenetically Normal Myeloid Malignancies.

Mediterranean Journal Of Hematology And Infectious Diseases
Atli, Emine Ikbal EI; Gurkan, Hakan H; Atli, Engin E; Kirkizlar, Hakki Onur HO; Yalcintepe, Sinem S; Demir, Selma S; Demirci, Ufuk U; Eker, Damla D; Mail, Cisem C; Kalkan, Rasime R; Demir, Ahmet Muzaffer AM
Publication Date: 2021

Variant appearance in text: TET2: 1916dupA
PubMed Link: 33489052
Variant Present in the following documents:
  • mjhid-13-1-e2021013.pdf
View BVdb publication page